CRISPR-based functional genomics in iPSC-based models of brain disease
Video · 1 h 2 min · Jul 30, 2020
Martin Kampmann, UCSF Department of Biochemistry and Biophysics
We use cookies for analytics.
Genetics, Epigenetics, Neuroscience and seminar by Prof Rudolf Jaenisch, MIT Department of Biology
Hosted by Ad hoc
Wednesday 13:15–14:25 Berlin (GMT+1)
Ended
Pluripotent cells, including embryonic stem (ES) and induced pluripotent stem (iPS) cells, are used to investigate the genetic and epigenetic underpinnings of human diseases such as Parkinson’s, Alzheimer’s, autism, and cancer. Mechanisms of somatic cell reprogramming to an embryonic pluripotent state are explored, utilizing patient-specific pluripotent cells to model and analyze neurodegenerative diseases.